Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4320-4325

  Hvalbye, Benedicte K R ^a   Aaberge, Ingeborg S ^a   Løvik, Martinus ^a   Haneberg, Bjørn ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOLOGICAL ADJUVANT; PNEUMOCOCCUS VACCINE; SODIUM CHLORIDE;

ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; LUNG LAVAGE; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0032785372     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4320-4325.1999     Document Type: Article

References (28)

1. Aaberge, I. S., J. Eng, G. Lermark, and M. Løvik. 1995. Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb. Pathog. 18: 141-152.
2. Aaberge, I. S., E.-C. Groeng, I. L. Haugen, R. Dalseg, M. Løvik, and B. Haneberg. 1995. Induction of systemic and mucosal antibodies to pneumococcal antigens by mucosal immunization. J. Cell. Biochem. Suppl. 19A:242.
3. Aaberge, I. S., and M. Løvik. 1996. The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens. APMIS 104:307-317.
4. Aaberge, I. S., T. E. Michaelsen, A. K. Rolstad, E.-C. Groeng, P. Solberg, and M. Løvik. 1992. Scid-hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect. Immun. 60:4146-4153.
5. Aaberge, I. S., R. J. North, E.-C. Groeng, and M. Lovik. 1993. Antibody response to pneumococcal polysaccharide vaccine in young, adult and old mice. Scand. J. Immunol. 38:17-30.
6. Abraham, E. 1992. Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 10:461-468.
7. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae. An overview. Clin. Infect. Dis. 15:77-83.
8. Bergquist, C., E.-L. Johansson, T. Lagergård, J. Holmgren, and A. Rudin. 1997. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65:2676-2684.
9. Berstad, A. K. H., J. Holst, B. Møgster, I. L. Haugen, and B. Haneberg. 1997. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Vaccine 15: 1473-1478.
10. Brandtzaeg, P. 1995. Molecular and cellular aspects of the secretory immunoglobulin system. APMIS 103:1-19.
11. Brandtzaeg, P., and B. Haneberg. 1997. Role of nasal-associated lymphoid tissue in the human mucosal immune system. Mucosal Immunol. Update 5:4-8.
12. Butler, J. C., R. F. Breiman, J. F. Campbell, H. B. Lipman, C. V. Broome, and R. R. Facklam. 1993. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 270:1826-1831.
13. Czerkinsky, C., and J. Holmgren. 1995. The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines. Immunologist 3:97-103.
14. Dalseg, R., E. Wedege, J. Holst, I. L. Haugen, E. A. Høiby, and B. Haneberg. 1999. Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice. Vaccine 17:2336-2345.
15. Gwaltney, J. M., Jr., M. A. Sande, R. Austrian, and J. O. Hendley. 1975. Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J. Infect. Dis. 132: 62-68.
16. Haneberg, B., R. Dalseg, E. Wedege, E. A. Høiby, I. L. Haugen, F. Oftung, S. R. Andersen, L. M. Næss, A. Aase, T. E. Michaelsen, and J. Holst. 1998. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect. Immun. 66:1334-1341.
17. Haneberg, B., D. Kendall, H. M. Amerongen, F. M. Apler, J.-P. Kraehenbuhl, and M. R. Neutra. 1994. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina, measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:15-23.
18. Hordnes, K., T. Tynning, T. A. Brown, B. Haneberg, and R. Jonsson. 1997. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice. Vaccine 15: 1244-1251.
19. Hvalbye, B., I. S. Aaberge, C. Peeters, and M. Løvik. 1995. Pneumococcal polysaccharide protein-conjugate vaccine in a mouse model: immune response and protection. Scand. J. Immunol. 41:622.
20. Koivula, I., M. Stén, M. Leinonen, and P. H. Mäkelä. 1997. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population based trial. Am. J. Med. 103:281-290.
21. Lee, C. J., and T. R. Wang. 1994. Pneumococcal infection and immunization in children. Crit. Rev. Microbiol. 20:1-12.
22. Obaro, S. K., M. A. Monteil, and D. C. Henderson. 1996. The pneumococcal problem. Brit. Med. J. 312:1521-1525.
23. Russell, M. W., Z. Moldoveanu, P. L. White, G. J. Sibert, J. Mestecky, and S. M. Michalek. 1996. Salivary, nasal, genital and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64:1272-1283.
24. Shapiro, E. D., A. T. Berg, R. Austrian, D. Schroeder, V. Parcells, A. Margolis, R. K. Adair, and J. D. Clemens. 1991. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1453-1460.
25. World Health Organization. 1993. Programme for the control of acute respiratory infections. Recent developments. Weekly Epidemiol. Rec. 68:353-360.
26. Wu, H.-Y., E. B. Nikolova, K. W. Beagley, and M. W. Russell. 1996. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue. Immunology 88:493-500.
27. Wu, H.-Y., M. H. Nahm, Y. Guo, M. W. Russel, and D. E. Briles. 1997. Intranasal immunization of mice with PspA (Pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J. Infect. Dis. 175:839-846.
28. Örtqvist, Å., J. Hedlund, L.-Å. Burman, E. Elbel, M. Höfer, M. Leinonen, I. Lindblad, B. Sundelöf, M. Kalin, and the Swedish Pneumococcal Vaccination Study Group. 1998. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 351:399-403.